GenVault

GenVault

Room-temperature biosample storage and management

Overview

GenVault stores and manages biological samples and genetic material at room temperature, offering a cost- and space-efficient alternative to traditional freezer storage. Its product lineup includes chemically treated papers and plates for collecting and storing samples, plus automated systems for handling, archiving, and retrieving them. The core idea is to stabilize DNA and RNA without refrigeration so samples stay viable over the long term, even in power outages. This differentiates GenVault from competitors by combining ambient-temperature preservation with automated sample management, reducing energy use and freezer maintenance costs. The company aims to provide scalable, reliable biosample storage and management that supports longitudinal research, drug discovery, and clinical diagnostics while cutting environmental and financial costs.

Significant Headcount Growth

About GenVault

Simplify's Rating
Why GenVault is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Robotics & Automation

Industrial & Manufacturing

Biotechnology

Healthcare

Company Size

11-50

Company Stage

Acquired

Total Funding

$85.6M

Headquarters

West Deptford Township, New Jersey

Founded

2001

Get referred to GenVault

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • August 2026 promotions target large transfers, especially 50,000-plus-sample collections.
  • The 2026 expanded facility gives GenVault immediate scale against smaller regional repositories.
  • Free retrieval on ambient storage through 2026 reduces switching friction for new customers.

What critics are saying

  • GenVault waives storage fees through 2026, signaling price pressure and unused capacity.
  • First-50-client promotion on 50,000-sample transfers shows aggressive sales tactics, not organic pull.
  • A single custody breach or contamination incident would destroy trust and trigger account exits.

What makes GenVault unique

  • 500,000-plus square feet of validated ambient, CRT, frozen, and cryogenic storage.
  • GxP-compliant biorepository design emphasizes chain-of-custody security over generic warehouse storage.
  • Room-temperature stabilization lowers freezer dependence, energy spend, and backup-power exposure.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$85.6M

Meets

Industry Average

Funded Over

8 Rounds

Acquisition funding comparison data is currently unavailable. We're working to provide this information soon!
Acquisition Funding Comparison
Coming Soon

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Company Paid Short-Term Disability

Company Paid Long-Term Disability

Accident/Critical Illness/Hospital Insurance

Pet Insurance Options

PTO

401K with Employer Match

Growth & Insights and Company News

Headcount

6 month growth

26%

1 year growth

26%

2 year growth

26%
Google
Aug 9th, 2023
GenVault Biorepository Announces Executive Director Appointment

WEST DEPTFORD, N.J., August 09, 2023--( BUSINESS WIRE )-- GenVault, one of the nation's most secure, comprehensive commercial facilities for bioinventory storage and transport, announces the appointment of Andrew Lee as executive director.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for GenVault right now.

Find jobs on Simplify and start your career today

We update GenVault's jobs every few hours, so check again soon! Browse all jobs →